Egg Freezing and Embryo Banking Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 – 2032
The Global Egg Freezing and Embryo Banking Market was valued at USD 4.3 billion in 2023 and is projected to indicate a robust CAGR of 9.8% from 2024 to 2032. oocyte cryopreservation, also known as Egg freezing, involves freezing, extracting, and storing a woman's eggs (oocytes) for potential future use. This method empowers women to safeguard their fertility, granting them the flexibility to conceive at a later date. On the other hand, embryo banking entails creating and preserving embryos for future applications. This process usually entails fertilizing a woman's eggs with sperm in a lab, subsequently freezing the resulting embryos for later implantation.
The overall egg freezing and embryo banking industry is classified based on service type, technology, application, storage duration, age group, and region. The egg freezing and embryo banking market is segmented by service type into egg freezing and embryo banking. In 2023, the embryo banking segment led the market, generating a substantial revenue of USD 2.7 billion. This modern approach resonates with changing lifestyles and the trend of delayed parenthood, allowing individuals to safeguard their fertility potential.
As societal acceptance and awareness grow, so does the demand for these services. The Human Fertilization & Embryology Authority's 2023 report highlights a 6.87% rise in embryo storage cycles in the UK for 2020 and a notable 17.18% surge in 2021, both compared to 2019 figures. The long-term storage segment, valued at USD 2.5 billion in 2023, emerged as the dominant player in the market. Shifts in societal and cultural perspectives, recognizing diverse family planning avenues, coupled with increasing backing from insurance firms and employers for fertility preservation benefits, are bolstering the long-term storage segment of the egg freezing and embryo banking market.
Moreover, there's a notable uptick in demand for these services, especially among cancer patients advised to consider egg freezing or embryo banking as a protective measure against potential fertility impairment from treatments. In 2023, the U.S. led the North American market, raking in a revenue of USD 1.7 billion. In the U.S. and Canada, a pronounced trend sees women postponing childbirth for reasons like career progression, advanced education, and personal choices. This has significantly fueled the region's market growth, as many women now view fertility preservation as a strategic move to harmonize their professional and personal aspirations.Furthermore, the financial backing from insurance entities and employers, who are progressively incorporating fertility preservation coverage in health plans, has alleviated the financial burden on individuals, enhancing accessibility to these procedures in the region.
The overall egg freezing and embryo banking industry is classified based on service type, technology, application, storage duration, age group, and region. The egg freezing and embryo banking market is segmented by service type into egg freezing and embryo banking. In 2023, the embryo banking segment led the market, generating a substantial revenue of USD 2.7 billion. This modern approach resonates with changing lifestyles and the trend of delayed parenthood, allowing individuals to safeguard their fertility potential.
As societal acceptance and awareness grow, so does the demand for these services. The Human Fertilization & Embryology Authority's 2023 report highlights a 6.87% rise in embryo storage cycles in the UK for 2020 and a notable 17.18% surge in 2021, both compared to 2019 figures. The long-term storage segment, valued at USD 2.5 billion in 2023, emerged as the dominant player in the market. Shifts in societal and cultural perspectives, recognizing diverse family planning avenues, coupled with increasing backing from insurance firms and employers for fertility preservation benefits, are bolstering the long-term storage segment of the egg freezing and embryo banking market.
Moreover, there's a notable uptick in demand for these services, especially among cancer patients advised to consider egg freezing or embryo banking as a protective measure against potential fertility impairment from treatments. In 2023, the U.S. led the North American market, raking in a revenue of USD 1.7 billion. In the U.S. and Canada, a pronounced trend sees women postponing childbirth for reasons like career progression, advanced education, and personal choices. This has significantly fueled the region's market growth, as many women now view fertility preservation as a strategic move to harmonize their professional and personal aspirations.Furthermore, the financial backing from insurance entities and employers, who are progressively incorporating fertility preservation coverage in health plans, has alleviated the financial burden on individuals, enhancing accessibility to these procedures in the region.
Report Content
CHAPTER 1 METHODOLOGY & SCOPE
1.1 Market scope & definition
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Industry 360° synopsis
CHAPTER 3 INDUSTRY INSIGHTS
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Growing awareness and acceptance of fertility preservation options among women and couples
3.2.1.2 Advancements in cryopreservation techniques
3.2.1.3 Rising global infertility rates
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost of egg freezing and embryo banking
3.2.2.2 Ethical and legal issues surrounding the use and disposition of frozen eggs and embryos
3.3 Growth potential analysis
3.4 Procedure volume of egg freezing and embryo banking cycles, 2021-2032
3.4.1 North America
3.4.2 Europe
3.4.3 Asia Pacific
3.4.4 Latin America
3.4.5 Middle East and Africa
3.5 Global cost analysis per cycle, 2023
3.6 Reimbursement scenario
3.7 Regulatory landscape
3.8 Technological landscape
3.9 Future market trends
3.10 Porter’s analysis
3.11 PESTEL analysis
CHAPTER 4 COMPETITIVE LANDSCAPE, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard
CHAPTER 5 MARKET ESTIMATES AND FORECAST, BY SERVICE TYPE, 2021 – 2032 ($ MN)
5.1 Key trends
5.2 Egg freezing
5.3 Embryo banking
CHAPTER 6 MARKET ESTIMATES AND FORECAST, BY STORAGE DURATION, 2021 – 2032 ($ MN)
6.1 Key trends
6.2 Short-term storage
6.3 Long-term storage
CHAPTER 7 MARKET ESTIMATES AND FORECAST, BY TECHNOLOGY, 2021 – 2032 ($ MN)
7.1 Key trends
7.2 Vitrification
7.3 Slow freezing
CHAPTER 8 MARKET ESTIMATES AND FORECAST, BY APPLICATION, 2021 – 2032 ($ MN)
8.1 Key trends
8.2 Fertility preservation
8.3 Donor egg/embryo programs
8.4 Genetic screening
8.5 Oncofertility
CHAPTER 9 MARKET ESTIMATES AND FORECAST, BY AGE GROUP, 2021 – 2032 ($ MN)
9.1 Key trends
9.2 Under
9.3 31 to
9.4 Over
CHAPTER 10 MARKET ESTIMATES AND FORECAST, BY REGION, 2021 – 2032 ($ MN)
10.1 Key trends
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 France
10.3.4 Spain
10.3.5 Italy
10.3.6 Netherlands
10.4 Asia Pacific
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 Australia
10.4.5 South Korea
10.5 Latin America
10.5.1 Brazil
10.5.2 Mexico
10.5.3 Argentina
10.6 Middle East and Africa
10.6.1 South Africa
10.6.2 Saudi Arabia
10.6.3 UAE
CHAPTER 11 COMPANY PROFILES
11.1 Boston IVF
11.2 Carrot
11.3 CCRM Fertility
11.4 Cryos International
11.5 Extend Fertility
11.6 Genea Pty
11.7 IVIRMA
11.8 Monash IVF Group
11.9 New Hope IVF & Fertility Clinic
11.10 Ovation Fertility
11.11 Progyny
11.12 ReproTech
11.13 RMA Network
11.14 Shady Grove Fertility
11.15 Spring Fertility
11.16 WINFertility
CHAPTER 1 METHODOLOGY & SCOPE
1.1 Market scope & definition
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Industry 360° synopsis
CHAPTER 3 INDUSTRY INSIGHTS
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Growing awareness and acceptance of fertility preservation options among women and couples
3.2.1.2 Advancements in cryopreservation techniques
3.2.1.3 Rising global infertility rates
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost of egg freezing and embryo banking
3.2.2.2 Ethical and legal issues surrounding the use and disposition of frozen eggs and embryos
3.3 Growth potential analysis
3.4 Procedure volume of egg freezing and embryo banking cycles, 2021-2032
3.4.1 North America
3.4.2 Europe
3.4.3 Asia Pacific
3.4.4 Latin America
3.4.5 Middle East and Africa
3.5 Global cost analysis per cycle, 2023
3.6 Reimbursement scenario
3.7 Regulatory landscape
3.8 Technological landscape
3.9 Future market trends
3.10 Porter’s analysis
3.11 PESTEL analysis
CHAPTER 4 COMPETITIVE LANDSCAPE, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard
CHAPTER 5 MARKET ESTIMATES AND FORECAST, BY SERVICE TYPE, 2021 – 2032 ($ MN)
5.1 Key trends
5.2 Egg freezing
5.3 Embryo banking
CHAPTER 6 MARKET ESTIMATES AND FORECAST, BY STORAGE DURATION, 2021 – 2032 ($ MN)
6.1 Key trends
6.2 Short-term storage
6.3 Long-term storage
CHAPTER 7 MARKET ESTIMATES AND FORECAST, BY TECHNOLOGY, 2021 – 2032 ($ MN)
7.1 Key trends
7.2 Vitrification
7.3 Slow freezing
CHAPTER 8 MARKET ESTIMATES AND FORECAST, BY APPLICATION, 2021 – 2032 ($ MN)
8.1 Key trends
8.2 Fertility preservation
8.3 Donor egg/embryo programs
8.4 Genetic screening
8.5 Oncofertility
CHAPTER 9 MARKET ESTIMATES AND FORECAST, BY AGE GROUP, 2021 – 2032 ($ MN)
9.1 Key trends
9.2 Under
9.3 31 to
9.4 Over
CHAPTER 10 MARKET ESTIMATES AND FORECAST, BY REGION, 2021 – 2032 ($ MN)
10.1 Key trends
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 France
10.3.4 Spain
10.3.5 Italy
10.3.6 Netherlands
10.4 Asia Pacific
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 Australia
10.4.5 South Korea
10.5 Latin America
10.5.1 Brazil
10.5.2 Mexico
10.5.3 Argentina
10.6 Middle East and Africa
10.6.1 South Africa
10.6.2 Saudi Arabia
10.6.3 UAE
CHAPTER 11 COMPANY PROFILES
11.1 Boston IVF
11.2 Carrot
11.3 CCRM Fertility
11.4 Cryos International
11.5 Extend Fertility
11.6 Genea Pty
11.7 IVIRMA
11.8 Monash IVF Group
11.9 New Hope IVF & Fertility Clinic
11.10 Ovation Fertility
11.11 Progyny
11.12 ReproTech
11.13 RMA Network
11.14 Shady Grove Fertility
11.15 Spring Fertility
11.16 WINFertility
